Stockpickr

Return to Article

Cramer's Take on Headline Stocks

Stockpickr Staff

Bernard Madoff, perpetrator of the multibillion-dollar Ponzi scheme that destroyed the financial health of hundreds, even thousands, of people, received a 150-year jail sentence on Monday morning.

Also making headlines, Microsoft(MSFT) might unload a 2007 acquisition, Razorfish, to a French marketing company. Microsoft closed up 51 cents, or $2.18, at $23.86 on Monday.

Swiss drug company Novartis(NVS) is reportedly considering a purchase of Elan's(ELN) multiple sclerosis treatment, Tsyabri, and other operations from the Irish biotech. Novartis closed down 17 cents at $41.17 on Monday, while Elan slid 41 cents, or 5.6%, to $6.95

And in analyst upgrade-downgrade news, Deutsche Bank downgraded Biogen Idec(BIIB) to hold from buy, Friedman Billings Ramsey downgraded Alcoa(AA) to underperform, and Credit Suisse upgraded KB Home(KBH) to neutral from underperform.

Biogen lost $2.75, or 5.5%, on Monday to close at $47.32; Alcoa slid 32 cents, or 3%, to $10.44; and KB Home added 69 cents, or 5.1%, to $14.11.

With this in mind, we thought we'd take a look at some of the stocks in the news and see what Jim Cramer's had to say about them lately.

To read more, visit Stockpickr.com.